Lighthouse Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.65M Buy
5,747
+558
+11% +$658K 2.99% 8
2026
Q2
$6.22M Buy
5,189
+51
+1% +$52.1K 3.23% 8
2026
Q1
$4.73M Buy
5,138
+527
+11% +$534K 2.85% 9
2025
Q4
$4.96M Buy
4,611
+85
+2% +$81.3K 3.24% 11
2025
Q3
$3.45M Buy
4,526
+17
+0.4% +$12.7K 2.28% 12
2025
Q2
$3.51M Buy
4,509
+110
+3% +$85.5K 2.69% 8
2025
Q1
$3.63M Buy
4,399
+58
+1% +$48.3K 3.14% 8
2024
Q4
$3.35M Buy
+4,341
New +$3.59M 2.72% 10

Other funds holding LLY

Lighthouse Financial's LLY Position: Q3 2026 in Review

Lighthouse Financial increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $658K and bringing the position to 5,747 shares worth $6.65M. The position accounts for 2.99% of the portfolio, ranked #8.

Lighthouse Financial first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Lighthouse Financial held 5,747 shares of Eli Lilly worth $6.65M as of Q3 2026.
  • Lighthouse Financial bought 558 Eli Lilly shares in Q3 2026, an estimated $658K.
  • Eli Lilly made up 2.99% of Lighthouse Financial's portfolio in Q3 2026, its #8 holding.
  • Lighthouse Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Lighthouse Financial's 13F filing for Q3 2026, filed 23 Oct 2026.